SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-14-003397
Filing Date
2014-10-09
Accepted
2014-10-09 09:17:05
Documents
3
Period of Report
2014-11-06
Effectiveness Date
2014-10-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT admp-def14a_110614.htm DEF 14A 550990
2 GRAPHIC image_001.jpg GRAPHIC 5422
3 GRAPHIC image_002.jpg GRAPHIC 2871
  Complete submission text file 0001387131-14-003397.txt   563867
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-36242 | Film No.: 141149299
SIC: 2834 Pharmaceutical Preparations